CPHI
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B is low, but likely reflects impaired asset values given the operational losses.
- P/B ratio of 0.43
- High P/S ratio (6.15) relative to negative margins
- No positive earnings for Graham Number calculation
Revenue growth is negligible compared to the scale of operating losses.
- Slight revenue growth
- Negative ROE (-20.91%)
- Negative ROA (-8.41%)
- Unsustainable cost structure
Long-term trend is a near-total loss of shareholder value.
- 5Y Change: -99.8%
- 1Y Change: -61.8%
- Consistent earnings misses in historical data
The company is facing an imminent liquidity crunch.
- Low Debt/Equity
- Piotroski F-Score 2/9
- Current Ratio 0.32
- Quick Ratio 0.09
Dividend strength is 0/100.
- No dividend paid
- No capacity for dividends
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CPHI and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CPHI
China Pharma Holdings, Inc.
Primary
|
-99.8% | -96.3% | -61.8% | -65.4% | -1.6% | -6.0% |
|
TXMD
TherapeuticsMD, Inc.
Peer
|
-96.5% | -41.7% | +118.0% | +86.3% | -5.6% | +3.3% |
|
DARE
Daré Bioscience, Inc.
Peer
|
-91.0% | -85.0% | -38.6% | -21.2% | +15.7% | -2.8% |
|
LFWD
Lifeward Ltd.
Peer
|
-96.0% | -88.2% | -60.6% | -26.0% | -1.6% | -4.2% |
|
ICCM
IceCure Medical Ltd
Peer
|
-97.0% | -71.2% | -71.9% | -62.9% | -51.7% | +7.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
CPHI
China Pharma Holdings, Inc.
|
BEARISH | $25.5M | - | -20.9% | -76.9% | $0.63 | |
|
TXMD
TherapeuticsMD, Inc.
|
BEARISH | $25.23M | - | -2.4% | -18.8% | $2.18 | Compare |
|
DARE
Daré Bioscience, Inc.
|
BEARISH | $25.77M | - | -% | -% | $1.77 | Compare |
|
LFWD
Lifeward Ltd.
|
BEARISH | $24.87M | - | -146.1% | -90.4% | $6.57 | Compare |
|
ICCM
IceCure Medical Ltd
|
BEARISH | $26.25M | - | -188.8% | -% | $0.32 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning CPHI from our newsroom.